SEVALENT
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Mar 2026)
What this means for you
This application is over — abandoned 16 Mar 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97583886
- Mark type
- Stylized text
- Filed
- 08 Sept 2022
- Published for opposition
- 17 Dec 2024
- Abandoned
- 16 Mar 2026
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for reducing, managing and relieving pain, treating addiction disorders and treating mental health illnesses; pharmaceutical preparations consisting of ketamine, flumazenil and psychedelics for the treatment of pain, addiction disorders and mental health illnesses; pharmaceutical preparations, namely, medicinal psychoactive psychedelic therapies for the treatment of pain, addiction disorders and mental health illnesses; drug delivery agents in the form of small molecules for the controlled release of therapeutic agents; wearable drug delivery devices, namely, subcutaneous pumps, sold filled with pharmaceutical preparations, for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnesses
- Class 010 — Medical apparatus: Wearable drug delivery devices sold empty, namely, subcutaneous pumps for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnesses
- Class 035 — Advertising and business services: providing business information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor
- Class 042 — Scientific and technological services: Medical and scientific research in the fields of addiction disorders, mental health illnesses, pain management, reduction and relief; developing modular subcutaneous delivery platforms for small molecules for controlled delivery of therapeutic agents; medical and scientific research and development in relation to pharmaceuticals and drug delivery platforms; providing scientific information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor
- Class 044 — Medical, beauty and agricultural services: providing medical information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor
- Class 045 — Legal and security services: providing regulatory compliance information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor
Owner
- Bexson Biomedical, Inc., Santa Barbara, CA, US
- Bexson Biomedical, Inc., Santa Barbara, CA, US
Prosecution history
- 16 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Aug 2025 — SOU EXTENSION 1 GRANTED
- 07 Aug 2025 — SOU EXTENSION 1 FILED
- 07 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2024 — PUBLISHED FOR OPPOSITION
- 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Jan 2024 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 12 Jul 2023 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 12 Jul 2023 — LETTER OF SUSPENSION E-MAILED
- 12 Jul 2023 — SUSPENSION LETTER WRITTEN